McVary KT - Search Results

1

Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW. Burnett AL, et al. Among authors: mcvary kt. J Urol. 2018 Sep;200(3):633-641. doi: 10.1016/j.juro.2018.05.004. Epub 2018 May 7. J Urol. 2018. PMID: 29746858

2

EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction.

Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K, Stecher V, Seftel AD. Althof SE, et al. Urology. 1999 Apr;53(4):793-9. doi: 10.1016/s0090-4295(98)00582-2. Urology. 1999. PMID: 10197859 Clinical Trial.

3

Testosterone supplementation for erectile dysfunction: results of a meta-analysis.

Jain P, Rademaker AW, McVary KT. Jain P, et al. Among authors: mcvary kt. J Urol. 2000 Aug;164(2):371-5. J Urol. 2000. PMID: 10893588

4

Smoking and erectile dysfunction: evidence based analysis.

McVary KT, Carrier S, Wessells H; Subcommittee on Smoking and Erectile Dysfunction Socioeconomic Committee, Sexual Medicine Society of North America. McVary KT, et al. J Urol. 2001 Nov;166(5):1624-32. J Urol. 2001. PMID: 11586190 Review.

5

Pharmacotherapy for erectile dysfunction.

Padma-Nathan H, Christ G, Adaikan G, Becher E, Brock G, Carrier S, Carson C, Corbin J, Francis S, DeBusk R, Eardley I, Hedlund H, Hutter A, Jackson G, Kloner R, Lin CS, McVary K, McCullough A, Nehra A, Porst H, Schulman C, Seftel A, Sharlip I, Stief C, Teloken C. Padma-Nathan H, et al. J Sex Med. 2004 Sep;1(2):128-40. doi: 10.1111/j.1743-6109.2004.04021.x. J Sex Med. 2004. PMID: 16422967

6

The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors.

Köhler TS, McVary KT. Köhler TS, et al. Among authors: mcvary kt. Eur Urol. 2009 Jan;55(1):38-48. doi: 10.1016/j.eururo.2008.08.062. Epub 2008 Sep 4. Eur Urol. 2009. PMID: 18783872 Review.

7

Effects of once-daily tadalafil on erectile function in men with erectile dysfunction and signs and symptoms of benign prostatic hyperplasia.

Porst H, McVary KT, Montorsi F, Sutherland P, Elion-Mboussa A, Wolka AM, Viktrup L. Porst H, et al. Among authors: mcvary kt. Eur Urol. 2009 Oct;56(4):727-35. doi: 10.1016/j.eururo.2009.04.033. Epub 2009 Apr 22. Eur Urol. 2009. PMID: 19409693 Clinical Trial.

8

Update on AUA guideline on the management of benign prostatic hyperplasia.

McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE Jr, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT. McVary KT, et al. J Urol. 2011 May;185(5):1793-803. doi: 10.1016/j.juro.2011.01.074. Epub 2011 Mar 21. J Urol. 2011. PMID: 21420124

9

A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy.

Mulhall JP, Burnett AL, Wang R, McVary KT, Moul JW, Bowden CH, DiDonato K, Shih W, Day WW. Mulhall JP, et al. Among authors: mcvary kt. J Urol. 2013 Jun;189(6):2229-36. doi: 10.1016/j.juro.2012.11.177. Epub 2012 Dec 3. J Urol. 2013. PMID: 23219537 Clinical Trial.

10

Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.

Brock GB, McVary KT, Roehrborn CG, Watts S, Ni X, Viktrup L, Wong DG, Donatucci C. Brock GB, et al. Among authors: mcvary kt. J Urol. 2014 Feb;191(2):405-11. doi: 10.1016/j.juro.2013.09.057. Epub 2013 Oct 1. J Urol. 2014. PMID: 24096120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page